Always consult your healthcare provider before starting any new supplement regimen.
Be careful of any instruction given during the administration and aftercare
When stratified by administration route, the average percentage reductions were: Intramuscular (IM): 48.3% Sublingual: 30.7% Oral: 30.3% These results suggest that IM administration leads the most pronounced homocysteine reduction, however, sublingual and oral routes also demonstrate clinically relevant effects
5-Amino-1MQ being explored in the prevention of adipogenesis, type II diabetes and in its potential to reverse diet-induced obesity
Digestive issues: Loss of appetite, weight loss, constipation, or diarrhea
Possible complications heart failure severe neurological deficits gastric cancer type 1 diabetes rheumatoid arthritis myasthenia gravis (a chronic condition causing muscle weakness) Hashimotos disease (an autoimmune condition affecting the thyroid) A pregnant or nursing person with a B12 deficiency When a person receives treatment for a B12 deficiency, they generally recover well and cease to have symptoms, although they may need to continue to use B12 nutritional supplements